JP2016027024A5 - - Google Patents

Download PDF

Info

Publication number
JP2016027024A5
JP2016027024A5 JP2015128359A JP2015128359A JP2016027024A5 JP 2016027024 A5 JP2016027024 A5 JP 2016027024A5 JP 2015128359 A JP2015128359 A JP 2015128359A JP 2015128359 A JP2015128359 A JP 2015128359A JP 2016027024 A5 JP2016027024 A5 JP 2016027024A5
Authority
JP
Japan
Prior art keywords
propenamide
fluorophenyl
optionally substituted
medicament according
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015128359A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016027024A (ja
JP6313264B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2015128359A priority Critical patent/JP6313264B2/ja
Priority claimed from JP2015128359A external-priority patent/JP6313264B2/ja
Publication of JP2016027024A publication Critical patent/JP2016027024A/ja
Publication of JP2016027024A5 publication Critical patent/JP2016027024A5/ja
Application granted granted Critical
Publication of JP6313264B2 publication Critical patent/JP6313264B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015128359A 2014-06-27 2015-06-26 ケイ皮酸アミド誘導体を含有する医薬 Expired - Fee Related JP6313264B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015128359A JP6313264B2 (ja) 2014-06-27 2015-06-26 ケイ皮酸アミド誘導体を含有する医薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014132060 2014-06-27
JP2014132060 2014-06-27
JP2015128359A JP6313264B2 (ja) 2014-06-27 2015-06-26 ケイ皮酸アミド誘導体を含有する医薬

Publications (3)

Publication Number Publication Date
JP2016027024A JP2016027024A (ja) 2016-02-18
JP2016027024A5 true JP2016027024A5 (enExample) 2017-02-16
JP6313264B2 JP6313264B2 (ja) 2018-04-18

Family

ID=55352602

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015128359A Expired - Fee Related JP6313264B2 (ja) 2014-06-27 2015-06-26 ケイ皮酸アミド誘導体を含有する医薬

Country Status (1)

Country Link
JP (1) JP6313264B2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2938615T3 (es) 2016-08-15 2023-04-13 Bayer Cropscience Ag Derivados del heterociclo bicíclico condensado como agentes de control de plagas
EP3498273A1 (en) * 2017-12-14 2019-06-19 Universität Wien Pharmaceutical composition for modulating the response of a gaba-a receptor
US12285395B2 (en) * 2018-06-07 2025-04-29 University-Industry Cooperation Group Of Kyung Hee University Pharmaceutical composition for preventing or treating allodynia caused by anticancer agents
CN118108655B (zh) * 2024-04-23 2024-06-28 四川大学华西医院 一类异吲哚啉-1,3-二酮衍生物、其制备方法、其用途和含该衍生物的药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5726266B2 (enExample) * 1973-07-17 1982-06-03
JP5210405B2 (ja) * 2010-03-17 2013-06-12 日本臓器製薬株式会社 アミノ酸誘導体を含有する医薬及び該誘導体の製造方法

Similar Documents

Publication Publication Date Title
RU2485131C2 (ru) Производные пиридина, замещенные гетероциклическим кольцом и фосфоноксиметильной группой и содержащие их противогрибковые средства
ES2660571T3 (es) Inhibidores de la proteína tirosina fosfatasa humana y su uso farmacéutico
RU2403247C2 (ru) Модуляторы никотиновых ацетилхолиновых рецепторов альфа 7 и их терапевтические применения
JP2016512825A5 (enExample)
JP2016512558A5 (enExample)
HRP20180199T1 (hr) Urea derivati ili njihove farmakološki prihvatljive soli korisni kao agonisti formil peptidnom receptoru-sličnom i (fprl-1)
HRP20180528T1 (hr) Derivati naftiridina, korisni kao antagonisti alfa-v-beta-6 integrina
JP2017523972A5 (enExample)
NZ597241A (en) Pharmaceutical dosage form for oral administration of a bcl-2 family inhibitor
WO2013009810A1 (en) Methods of treatment
JP2017530983A5 (enExample)
WO2013009830A1 (en) Methods of treatment
JP2016528301A5 (enExample)
JP2016027024A5 (enExample)
JP2014528464A5 (enExample)
PH12021550687A1 (en) Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or its salt
JP2016512507A5 (enExample)
JP2004509857A5 (enExample)
JP2015510916A5 (enExample)
JP2013512247A5 (enExample)
RU2015117647A (ru) Новые производные пиразола
JP2007532607A5 (enExample)
JP2008503533A5 (enExample)
EP2455080A1 (en) S1P1 receptor agonists for use in the treatment of multiple sclerosis
JP2021504384A5 (enExample)